ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,626.54
-0.14%
US Tech 100
19,043.65
-0.81%
Dow Jones
41,270.50
0.23%
Brent Oil
80.125
2.23%
Bitcoin
63,740.42
-0.96%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Geron Corp (GERN)

  7. Geron Corp (GERN) News

GERN

Geron (GERN)

Geron Corp
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GERN
DateTimeSourceHeadlineSymbolCompany
08/22/20244:30PMBusiness WireGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GERNGeron Corp
08/08/20247:00AMBusiness WireGeron Corporation Reports Second Quarter 2024 Financial Results and Business HighlightsNASDAQ:GERNGeron Corp
07/26/20247:30AMBusiness WireGeron Announces Updated NCCN Guidelines® Recommending RYTELO™ (imetelstat) for the Treatment of Symptomatic Anemia in Patients with Lower-Risk MDSNASDAQ:GERNGeron Corp
07/23/20244:15PMBusiness WireGeron Corporation Announces Chief Commercial Officer to Depart at End of August 2024NASDAQ:GERNGeron Corp
07/18/20244:30PMBusiness WireGeron to Announce Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:GERNGeron Corp
07/10/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
07/08/20243:44PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GERNGeron Corp
06/20/20244:30PMBusiness WireGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GERNGeron Corp
06/12/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
06/12/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
06/10/20245:53PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GERNGeron Corp
06/10/202412:30PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GERNGeron Corp
06/07/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
06/07/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
06/07/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
06/07/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
06/07/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
06/07/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
06/07/20244:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GERNGeron Corp
06/06/20249:58PMBusiness WireGeron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent AnemiaNASDAQ:GERNGeron Corp
06/05/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
06/04/20245:02PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GERNGeron Corp
05/17/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GERNGeron Corp
05/16/20244:30PMBusiness WireGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GERNGeron Corp
05/15/20244:07PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GERNGeron Corp
05/13/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GERNGeron Corp
05/02/20247:00AMBusiness WireGeron Corporation Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:GERNGeron Corp
04/25/20244:30PMBusiness WireGeron to Announce First Quarter 2024 Financial Results on May 2, 2024NASDAQ:GERNGeron Corp
04/18/20244:30PMBusiness WireGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GERNGeron Corp
04/03/20244:30PMBusiness WireGeron to Participate at Upcoming Investor Conferences in AprilNASDAQ:GERNGeron Corp
 Showing the most relevant articles for your search:NASDAQ:GERN

Your Recent History

USOTC
ITUP
Interups (CE)
USOTC
MONI
Moon Equity (PK)
USOTC
RONN
Ronn Motor (PK)
NASDAQ
MULN
Mullen Automotive
NASDAQ
NVDA
NVIDIA
USOTC
ABQQ
AB (PK)
USOTC
SINC
Sincerity Applied Materi... (PK)
COIN
XRPUSD
Ripple
USOTC
XERI
Xeriant (QB)
NASDAQ
COOP
Mr Cooper
USOTC
TPTW
TPT Global Tech (CE)
USOTC
WDLF
Decentral Life (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
NYSE
AMC
AMC Entertainment
USOTC
FNMA
Fannie Mae (QB)
USOTC
ERHE
ERHC Energy (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved